Signaling Pathway
Aprutumab (BAY 1179470) is a fully human monoclonal antibody targeting the fibroblast growth factor receptor 2 (FGFR2). It exhibits specific binding affinity to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc. This antibody is primarily explored for its applicability in the study of solid tumors, offering significant potential for research into cancer biology and therapeutic development.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Aprutumab (BAY 1179470) is a fully human monoclonal antibody targeting the fibroblast growth factor receptor 2 (FGFR2). It exhibits specific binding affinity to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc. This antibody is primarily explored for its applicability in the study of solid tumors, offering significant potential for research into cancer biology and therapeutic development. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
